Tumor Marker Testing Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: T1B65B71CAD4EN
Market Monitor Global

Abstracts

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.

This report contains market size and forecasts of Tumor Marker Testing in Global, including the following market information:

Global Tumor Marker Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tumor Marker Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biochemical Markers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tumor Marker Testing include Abbott Diagnostics, Affymetrix, Agilent Technologies, Beckman Dickinson?BD?, BioCurex, BioModa, Clarient, Correlogic Systems and Epigenomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Marker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tumor Marker Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tumor Marker Testing Market Segment Percentages, by Type, 2021 (%)

• Biochemical Markers
• Oncogenes
• Growth Factors
• Hormones
• Colony Stimulating Factors
• Lymphokines
• Immunohistochemical Stains
• Others

Global Tumor Marker Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tumor Marker Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Commercial/Private Laboratories
• Physician Offices/Group Practices
• Cancer Clinics
• Ambulatory Care Centers

Global Tumor Marker Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tumor Marker Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tumor Marker Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tumor Marker Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Diagnostics
• Affymetrix
• Agilent Technologies
• Beckman Dickinson?BD?
• BioCurex
• BioModa
• Clarient
• Correlogic Systems
• Epigenomics
• Hologic
• Roche Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tumor Marker Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tumor Marker Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TUMOR MARKER TESTING OVERALL MARKET SIZE

2.1 Global Tumor Marker Testing Market Size: 2021 VS 2028
2.2 Global Tumor Marker Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tumor Marker Testing Players in Global Market
3.2 Top Global Tumor Marker Testing Companies Ranked by Revenue
3.3 Global Tumor Marker Testing Revenue by Companies
3.4 Top 3 and Top 5 Tumor Marker Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tumor Marker Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Marker Testing Players in Global Market
  3.6.1 List of Global Tier 1 Tumor Marker Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tumor Marker Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tumor Marker Testing Market Size Markets, 2021 & 2028
  4.1.2 Biochemical Markers
  4.1.3 Oncogenes
  4.1.4 Growth Factors
  4.1.5 Hormones
  4.1.6 Colony Stimulating Factors
  4.1.7 Lymphokines
  4.1.8 Immunohistochemical Stains
  4.1.9 Others
4.2 By Type - Global Tumor Marker Testing Revenue & Forecasts
  4.2.1 By Type - Global Tumor Marker Testing Revenue, 2017-2022
  4.2.2 By Type - Global Tumor Marker Testing Revenue, 2023-2028
  4.2.3 By Type - Global Tumor Marker Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tumor Marker Testing Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Commercial/Private Laboratories
  5.1.4 Physician Offices/Group Practices
  5.1.5 Cancer Clinics
  5.1.6 Ambulatory Care Centers
5.2 By Application - Global Tumor Marker Testing Revenue & Forecasts
  5.2.1 By Application - Global Tumor Marker Testing Revenue, 2017-2022
  5.2.2 By Application - Global Tumor Marker Testing Revenue, 2023-2028
  5.2.3 By Application - Global Tumor Marker Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tumor Marker Testing Market Size, 2021 & 2028
6.2 By Region - Global Tumor Marker Testing Revenue & Forecasts
  6.2.1 By Region - Global Tumor Marker Testing Revenue, 2017-2022
  6.2.2 By Region - Global Tumor Marker Testing Revenue, 2023-2028
  6.2.3 By Region - Global Tumor Marker Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tumor Marker Testing Revenue, 2017-2028
  6.3.2 US Tumor Marker Testing Market Size, 2017-2028
  6.3.3 Canada Tumor Marker Testing Market Size, 2017-2028
  6.3.4 Mexico Tumor Marker Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tumor Marker Testing Revenue, 2017-2028
  6.4.2 Germany Tumor Marker Testing Market Size, 2017-2028
  6.4.3 France Tumor Marker Testing Market Size, 2017-2028
  6.4.4 U.K. Tumor Marker Testing Market Size, 2017-2028
  6.4.5 Italy Tumor Marker Testing Market Size, 2017-2028
  6.4.6 Russia Tumor Marker Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Tumor Marker Testing Market Size, 2017-2028
  6.4.8 Benelux Tumor Marker Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tumor Marker Testing Revenue, 2017-2028
  6.5.2 China Tumor Marker Testing Market Size, 2017-2028
  6.5.3 Japan Tumor Marker Testing Market Size, 2017-2028
  6.5.4 South Korea Tumor Marker Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Tumor Marker Testing Market Size, 2017-2028
  6.5.6 India Tumor Marker Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tumor Marker Testing Revenue, 2017-2028
  6.6.2 Brazil Tumor Marker Testing Market Size, 2017-2028
  6.6.3 Argentina Tumor Marker Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tumor Marker Testing Revenue, 2017-2028
  6.7.2 Turkey Tumor Marker Testing Market Size, 2017-2028
  6.7.3 Israel Tumor Marker Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Tumor Marker Testing Market Size, 2017-2028
  6.7.5 UAE Tumor Marker Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Diagnostics
  7.1.1 Abbott Diagnostics Corporate Summary
  7.1.2 Abbott Diagnostics Business Overview
  7.1.3 Abbott Diagnostics Tumor Marker Testing Major Product Offerings
  7.1.4 Abbott Diagnostics Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Diagnostics Key News
7.2 Affymetrix
  7.2.1 Affymetrix Corporate Summary
  7.2.2 Affymetrix Business Overview
  7.2.3 Affymetrix Tumor Marker Testing Major Product Offerings
  7.2.4 Affymetrix Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.2.5 Affymetrix Key News
7.3 Agilent Technologies
  7.3.1 Agilent Technologies Corporate Summary
  7.3.2 Agilent Technologies Business Overview
  7.3.3 Agilent Technologies Tumor Marker Testing Major Product Offerings
  7.3.4 Agilent Technologies Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.3.5 Agilent Technologies Key News
7.4 Beckman Dickinson?BD?
  7.4.1 Beckman Dickinson?BD? Corporate Summary
  7.4.2 Beckman Dickinson?BD? Business Overview
  7.4.3 Beckman Dickinson?BD? Tumor Marker Testing Major Product Offerings
  7.4.4 Beckman Dickinson?BD? Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.4.5 Beckman Dickinson?BD? Key News
7.5 BioCurex
  7.5.1 BioCurex Corporate Summary
  7.5.2 BioCurex Business Overview
  7.5.3 BioCurex Tumor Marker Testing Major Product Offerings
  7.5.4 BioCurex Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.5.5 BioCurex Key News
7.6 BioModa
  7.6.1 BioModa Corporate Summary
  7.6.2 BioModa Business Overview
  7.6.3 BioModa Tumor Marker Testing Major Product Offerings
  7.6.4 BioModa Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.6.5 BioModa Key News
7.7 Clarient
  7.7.1 Clarient Corporate Summary
  7.7.2 Clarient Business Overview
  7.7.3 Clarient Tumor Marker Testing Major Product Offerings
  7.7.4 Clarient Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.7.5 Clarient Key News
7.8 Correlogic Systems
  7.8.1 Correlogic Systems Corporate Summary
  7.8.2 Correlogic Systems Business Overview
  7.8.3 Correlogic Systems Tumor Marker Testing Major Product Offerings
  7.8.4 Correlogic Systems Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.8.5 Correlogic Systems Key News
7.9 Epigenomics
  7.9.1 Epigenomics Corporate Summary
  7.9.2 Epigenomics Business Overview
  7.9.3 Epigenomics Tumor Marker Testing Major Product Offerings
  7.9.4 Epigenomics Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.9.5 Epigenomics Key News
7.10 Hologic
  7.10.1 Hologic Corporate Summary
  7.10.2 Hologic Business Overview
  7.10.3 Hologic Tumor Marker Testing Major Product Offerings
  7.10.4 Hologic Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.10.5 Hologic Key News
7.11 Roche Diagnostics
  7.11.1 Roche Diagnostics Corporate Summary
  7.11.2 Roche Diagnostics Business Overview
  7.11.3 Roche Diagnostics Tumor Marker Testing Major Product Offerings
  7.11.4 Roche Diagnostics Tumor Marker Testing Revenue in Global Market (2017-2022)
  7.11.5 Roche Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tumor Marker Testing Market Opportunities & Trends in Global Market
Table 2. Tumor Marker Testing Market Drivers in Global Market
Table 3. Tumor Marker Testing Market Restraints in Global Market
Table 4. Key Players of Tumor Marker Testing in Global Market
Table 5. Top Tumor Marker Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tumor Marker Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tumor Marker Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tumor Marker Testing Product Type
Table 9. List of Global Tier 1 Tumor Marker Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Marker Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tumor Marker Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tumor Marker Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tumor Marker Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tumor Marker Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tumor Marker Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tumor Marker Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tumor Marker Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tumor Marker Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tumor Marker Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tumor Marker Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tumor Marker Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tumor Marker Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tumor Marker Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tumor Marker Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tumor Marker Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tumor Marker Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tumor Marker Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tumor Marker Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tumor Marker Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Diagnostics Corporate Summary
Table 31. Abbott Diagnostics Tumor Marker Testing Product Offerings
Table 32. Abbott Diagnostics Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 33. Affymetrix Corporate Summary
Table 34. Affymetrix Tumor Marker Testing Product Offerings
Table 35. Affymetrix Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Tumor Marker Testing Product Offerings
Table 38. Agilent Technologies Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 39. Beckman Dickinson?BD? Corporate Summary
Table 40. Beckman Dickinson?BD? Tumor Marker Testing Product Offerings
Table 41. Beckman Dickinson?BD? Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 42. BioCurex Corporate Summary
Table 43. BioCurex Tumor Marker Testing Product Offerings
Table 44. BioCurex Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 45. BioModa Corporate Summary
Table 46. BioModa Tumor Marker Testing Product Offerings
Table 47. BioModa Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 48. Clarient Corporate Summary
Table 49. Clarient Tumor Marker Testing Product Offerings
Table 50. Clarient Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 51. Correlogic Systems Corporate Summary
Table 52. Correlogic Systems Tumor Marker Testing Product Offerings
Table 53. Correlogic Systems Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 54. Epigenomics Corporate Summary
Table 55. Epigenomics Tumor Marker Testing Product Offerings
Table 56. Epigenomics Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 57. Hologic Corporate Summary
Table 58. Hologic Tumor Marker Testing Product Offerings
Table 59. Hologic Tumor Marker Testing Revenue (US$, Mn), (2017-2022)
Table 60. Roche Diagnostics Corporate Summary
Table 61. Roche Diagnostics Tumor Marker Testing Product Offerings
Table 62. Roche Diagnostics Tumor Marker Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tumor Marker Testing Segment by Type in 2021
Figure 2. Tumor Marker Testing Segment by Application in 2021
Figure 3. Global Tumor Marker Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tumor Marker Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tumor Marker Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Marker Testing Revenue in 2021
Figure 8. By Type - Global Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 12. US Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 16. Germany Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 24. China Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tumor Marker Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tumor Marker Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Diagnostics Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affymetrix Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Agilent Technologies Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beckman Dickinson?BD? Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioCurex Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioModa Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Clarient Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Correlogic Systems Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Epigenomics Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Hologic Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Diagnostics Tumor Marker Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)